Trial intelligence / Profile preview

Optimization of colonoscopy preparation in inflammatory bowel disease

2018-001402-28Phase 4Active

Sponsor
Hospital Universitario La Paz
Start
Jan 2019
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of macrogol and sodium picosulfate in inflammatory bowel disease (IBD) (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Bowel preparation quality by Boston Bowel Preparation Scale. Started Jan 2019; status: active.

02

Drugs

macrogolsodium picosulfate
03

Conditions

inflammatory bowel disease (IBD)

Beyond the preview

Go deeper on 2018-001402-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001402-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call